2 ASX AI shares that could be set to soar in 2024 and beyond

Analysts think these shares with AI exposure are top buys and destined for strong growth.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share market has been getting very excited about the artificial intelligence (AI) megatrend this year.

And rightly so. It's no exaggeration to say that AI is going to change the world.

We've only really had a small taste of this in the last few years but expect things to accelerate as AI continues to improve and more money is invested in the space.

The good news for investors is that there are ways to gain exposure to AI with ASX shares.

And I don't mean with supposed AI shares like Brainchip Holdings Ltd (ASX: BRN), which has promised the world and delivered nothing in a market dominated by a US$3 trillion behemoth.

I mean with genuine industry leaders that are leveraging AI to cement their position and drive long-term growth. Let's take a look at two:

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares

Image source: Getty Images

Pro Medicus Limited (ASX: PME)

The first ASX AI share to look at is health imaging technology company Pro Medicus,

Goldman Sachs recently spoke about how the company's AI revenues could grow from a small percentage of its overall sales into something significant in the future. It said:

AI opens an incremental US$620mn TAM today (growing at a +34.7% CAGR) with radiology receiving the majority (c.80%) of recent FDA AI algorithm clearance. We believe PME is well positioned to take share as the incumbent viewing platform across many large, and likely early adopters of new technology.

PME is generating revenue from its Visage breast density AI algorithm (developed via a partnership with Yale) today, and we see the potential value for AI to be significant with adoption driven by improved accuracy and clinical outcomes. We forecast AI to comprise 9% of PME's revenue by FY30E (from <1% in FY25E), with upside if PME achieves faster AI attach penetration, higher price per scan, and a greater proportion of algorithms developed in-house where no royalties are paid to a partner.

Goldman has a buy rating and $136.00 price target on its shares.

NextDC Ltd (ASX: NXT)

Another ASX AI share to look at is data centre operator NextDC. While it isn't necessarily offering AI services, it is servicing the huge data centre demand for capacity that AI needs to function.

In April, Goldman Sachs commented on this. It said:

NextDC believes AI is driving global data centre growth from 15% to 19% with Australia and broader APAC remaining well-positioned for growth and the fastest growing region. AI is increasing average power density racks (kW/Rack) growing 2.5x to c80-100kW. NXT are seeing demand pipeline for singular deals in the vicinity of 50-100MW and see market growth accelerating. AI demand is also stemming from a 40%/60% mix from inference/training, with upside for inference to reach 70%.

The broker currently has a buy rating and $18.59 price target on its shares. Though, it is worth noting that other brokers are even more bullish. For example, Morgan Stanley has an overweight rating and $20.00 price target.

Motley Fool contributor James Mickleboro has positions in Nextdc and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A girl is looking very confused, with one eyebrow raised saying what?
Technology Shares

What on earth is going on with the WiseTech share price?

WiseTech shares have dropped into the red again today after a great rally.

Read more »

A warehouse worker is standing next to a shelf and using a digital tablet.
Technology Shares

What's Macquarie saying about the Wisetech share price ahead of results?

After a difficult year, are these shares due for some upside?

Read more »

A group of three young men sit on a sofa in a home environment with a bowl of popcorn and beer bottles in front of them cheering on one of their teams on a phone.
Earnings Results

Light & Wonder earnings: Q2 profit and recurring revenue up in FY26

Recurring revenue reached US$580 million in the second quarter.

Read more »

Smiling young parents with their daughter dream of success.
Technology Shares

Why Life360 shares could be a strong buy this month

Looking for big returns? Bell Potter expects this tech stock to surge.

Read more »

A woman in a red dress holding up a red graph.
Technology Shares

How high does Macquarie think Life360 shares will go?

This tech company is looking undervalued.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 23% and 58%, should I buy TechnologyOne and Xero shares now?

A leading expert provides his forecasts for TechnologyOne and Xero shares.

Read more »

A blue globe outlined against a black background.
Technology Shares

A rare buying opportunity in 1 of Australia's top shares?

I think this business could be significantly undervalued.

Read more »

A mother and her young son are lying on the floor of their lounge sharing a tech device.
Technology Shares

Should you buy Life360 and Xero shares in August?

Millions of customers already rely on these platforms, and each business is finding new ways to become more valuable to…

Read more »